Arcus Biosciences, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-53.1M | $-18.0M |
| Depreciation & Amortization | $2.6M | $1.3M |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $495.0K | $90.0K |
| Net Cash from Operating Activities | $-25.1M | $-12.9M |
| Investing Activities | ||
| Capital Expenditures | $5.5M | $4.1M |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-49.1M | $-38.9M |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $107.4M | $70.1M |
| Net Change in Cash | $33.3M | $18.3M |
| Free Cash Flow | $-30.6M | $-17.0M |